Sign inJoin waitlistJoin the waitlist

Sonali Smith

Section Chief · University of Chicago Medical Center

Credentials: · · ·

History

University of Chicago Medical Center
Present
University of Chicago Medical Center
Present
University of Chicago Medical Center
Present

University of Chicago Medical Center
2000–2002
Northwestern University
1997–2000
Internal Medicine
University of Virginia Medical Center
1994–1997
Northwestern University Feinberg School of Medicine
1990–1994

Research

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood · 2022 · 1,363 citations
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
New England Journal of Medicine · 2018 · Last of 21 authors · 972 citations
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies
Journal of Clinical Oncology · 2013 · 935 citations

Jonathan Friedberg
40 papers
John Leonard
33 papers
BK
Brad Kahl
32 papers
Ranjana Advani
29 papers
Andrew Evens
28 papers
Justin Kline
24 papers
Nancy Bartlett
24 papers
TF
Timothy Fenske
22 papers
Lisa Rimsza
19 papers
Mohamed Dabaja
19 papers
Hillard Lazarus
18 papers
Koen van Besien
18 papers · 6 as a resident

Grants

Developing an Oncology Workforce for the 21st Century
National Cancer Institute · K12
PI · $3.4M · University of Chicago
2010–2026

Clinical trials

A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma
Principal investigator · Terminated · Phase 1, Phase 2
University of Chicago
2021–2023
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
Principal investigator · Completed · Phase 1, Phase 2
University of Chicago
2014–2024
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)
2010–2018
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2004